Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COBZ
1551
DELISTED
CoBiz Financial,Inc
COBZ
| $2.81M | 0.01% |
260,715
-27,618
| -10% | -$292K |
|
|
ALR
1552
DELISTED
Alere Inc
ALR
| $2.8M | 0.01% |
74,924
-219,400
| -75% | -$7.81M |
|
1553
Cincinnati Financial
CINF
$26.6B
| $2.79M | 0.01% |
58,000
-493,400
| -89% | -$24M |
|
1554
Federal Signal
FSS
$7.72B
| $2.78M | 0.01% |
189,800
-153,720
| -45% | -$2.25M |
|
|
RALY
1555
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $2.78M | 0.01% |
+254,900
| New | +$3.17M |
|
|
CEA
1556
DELISTED
China Eastern Airlines
CEA
| $2.77M | 0.01% |
181,300
-13,800
| -7% | -$217K |
|
1557
UNIFI
UFI
$122M
| $2.77M | 0.01% |
100,500
-10,700
| -10% | -$252K |
|
|
BPZ
1558
DELISTED
BPZ RESOURCES INC COM STK
BPZ
| $2.77M | 0.01% |
898,073
-532,031
| -37% | -$1.55M |
|
1559
Advanced Micro Devices
AMD
$829B
| $2.77M | 0.01% |
+659,926
| New | +$2.67M |
|
|
NATI
1560
DELISTED
National Instruments Corp
NATI
| $2.76M | 0.01% |
85,266
-1,800
| -2% | -$51.7K |
|
1561
Compañía de Minas Buenaventura
BVN
$8.53B
| $2.75M | 0.01% |
233,300
-504,094
| -68% | -$5.79M |
|
1562
Regis Corp
RGS
$69.3M
| $2.75M | 0.01% |
9,785
-1,040
| -10% | -$282K |
|
|
SNAK
1563
DELISTED
Inventure Foods, Inc.
SNAK
| $2.75M | 0.01% |
243,900
+16,403
| +7% | +$207K |
|
|
PACD
1564
DELISTED
Pacific Drilling S A
PACD
| $2.75M | 0.01% |
27,470
+24,660
| +878% | +$2.47M |
|
|
SALE
1565
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $2.74M | 0.01% |
103,100
-74,750
| -42% | -$2.17M |
|
|
ARMH
1566
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $2.73M | 0.01% |
+60,400
| New | +$2.8M |
|
1567
Merit Medical Systems
MMSI
$5.42B
| $2.72M | 0.01% |
179,944
-57,003
| -24% | -$789K |
|
1568
British American Tobacco
BTI
$123B
| $2.71M | 0.01% |
+45,600
| New | +$2.67M |
|
|
HNR
1569
DELISTED
Harvest Natural Resources
HNR
| $2.71M | 0.01% |
135,759
+60,434
| +80% | +$1.13M |
|
|
SASR
1570
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.71M | 0.01% |
108,600
-4,289
| -4% | -$104K |
|
|
KRA
1571
DELISTED
Kraton Corporation
KRA
| $2.71M | 0.01% |
120,800
-20,637
| -15% | -$528K |
|
|
STON
1572
DELISTED
StoneMor Inc.
STON
| $2.69M | 0.01% |
111,206
+84,987
| +324% | +$2.07M |
|
1573
C&F Financial
CFFI
$286M
| $2.69M | 0.01% |
74,639
-2,221
| -3% | -$74.7K |
|
|
TBHC
1574
DELISTED
The Brand House Collective
TBHC
| $2.68M | 0.01% |
144,300
-59,476
| -29% | -$1.05M |
|
|
AMAG
1575
DELISTED
AMAG Pharmaceuticals
AMAG
| $2.67M | 0.01% |
129,060
+3,900
| +3% | +$72.1K |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.